Australia - English - Department of Health (Therapeutic Goods Administration)

boston scientific pty ltd - 36143 - prosthesis, internal, stent, pancreatic - the advanix pancreatic stent is designed for pancreatic duct (pd) drainage.

Australia - English - Department of Health (Therapeutic Goods Administration)

william a cook australia pty ltd - 36143 - prosthesis, internal, stent, pancreatic - used to drain obstructed pancreatic ducts and are supplied sterile, disposable and intended for single use only.

New Zealand - English - Medsafe (Medicines Safety Authority)

viatris limited - pancreatin 420mg (amylase 25,200 ph eur u, lipase 35,000 ph eur u, protease 1,400 ph eur u.); pancreatin 420mg (amylase 25,200 ph eur u, lipase 35,000 ph eur u, protease 1,400 ph eur u.) - modified release capsule - 420 mg - active: pancreatin 420mg (amylase 25,200 ph eur u, lipase 35,000 ph eur u, protease 1,400 ph eur u.) excipient: cetyl alcohol dimeticone gelatin hypromellose phthalate iron oxide black iron oxide red iron oxide yellow macrogol 4000 sodium laurilsulfate titanium dioxide triethyl citrate active: pancreatin 420mg (amylase 25,200 ph eur u, lipase 35,000 ph eur u, protease 1,400 ph eur u.) excipient: cetyl alcohol dimeticone gelatin hypromellose phthalate iron oxide red iron oxide yellow macrogol 4000 sodium laurilsulfate triethyl citrate - creon is indicated for the treatment of pancreatic exocrine insufficiency (pei) in paediatric and adult patients. pancreatic exocrine insufficiency is often associated with, but not limited to: · cystic fibrosis · chronic pancreatitis · post-pancreatectomy · post-gastrointestinal bypass surgery ,(e.g. billroth ii, gastroenterostomy) · ductal obstruction of the pancreas or common bile duct (e.g. from neoplasm).

New Zealand - English - Medsafe (Medicines Safety Authority)

viatris limited - pancreatin 300mg (amylase 16,000 ph eur u, lipase 20,000 ph eur u, protease 1,200 ph eur u.) - modified release capsule - 300 mg - active: pancreatin 300mg (amylase 16,000 ph eur u, lipase 20,000 ph eur u, protease 1,200 ph eur u.) excipient: cetyl alcohol dimeticone gelatin hypromellose phthalate iron oxide black iron oxide red iron oxide yellow macrogol 4000 sodium laurilsulfate titanium dioxide triethyl citrate - creon is indicated for the treatment of pancreatic exocrine insufficiency (pei) in paediatric and adult patients. pancreatic exocrine insufficiency is often associated with, but not limited to: · cystic fibrosis · chronic pancreatitis · post-pancreatectomy · post-gastrointestinal bypass surgery ,(e.g. billroth ii, gastroenterostomy) · ductal obstruction of the pancreas or common bile duct (e.g. from neoplasm).

United States - English - NLM (National Library of Medicine)

seroyal usa - oryctolagus cuniculus whole (unii: 768be616l8) (oryctolagus cuniculus whole - unii:768be616l8) - oryctolagus cuniculus whole 3 [hp_x] - indications for the temporary relief of symptoms associated with gastrointestinal discomforts indications for the temporary relief of symptoms associated with gastrointestinal discomforts directions adults: take five granules three times daily or as recommended by your healthcare practitioner. children: take three granules and follow adult directions.

Australia - English - Department of Health (Therapeutic Goods Administration)

health world limited - pancreatin -

Canada - English - Health Canada

total health centre - pancreatin - drops - 30c - pancreatin 30c - homeopathic products

Namibia - English - Namibia Medicines Regulatory Council

msd (pty) ltd - pancreatin - capsules - pancreatin capsules 150mg

Namibia - English - Namibia Medicines Regulatory Council

msd (pty) ltd - pancreatin - capsules - pancreatin capsules 300mg

Australia - English - Department of Health (Therapeutic Goods Administration)

endotherapeutics pty ltd - 63968 - polymeric biliary/pancreatic stent - polymeric stent with a fluted, cross-sectional profile and containing two channels which spiral in a double helix down the length of the stent. the archimedes bps is designed to fit the natural curvature of the common bile duct and pancreatic duct. the ends of the archimedes bps are tapered to allow insertion through the papilla. the minimal strength retention time for the archimedes bps fast degradation profile is 12 days. the process in which archimedes bps degrades is through hydrolysis. the archimedes bps is used to drain obstructed biliary or pancreatic ducts and is indicated for obstructed biliary and pancreatic ducts. the archimedes bps fast degradation profile is intended to degrade over a period of 12 days.